Stephen Tatter
Overview
Explore the profile of Stephen Tatter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
270
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdulhaleem M, Ruiz J, ONeill S, Hughes R, Qasem S, Strowd R, et al.
Neurooncol Adv
. 2023 Feb;
5(1):vdac186.
PMID: 36789023
Background: Leptomeningeal failure (LMF) represents a devastating progression of disease following resection of brain metastases (BrM). We sought to identify a biomarker at time of BrM resection that predicts for...
2.
Razavian N, Helis C, Laxton A, Tatter S, Bourland J, Mott R, et al.
J Neurooncol
. 2022 Oct;
161(2):259-266.
PMID: 36222952
Purpose: Data on the efficacy and safety of stereotactic radiosurgery (SRS) for treatment of radiation-induced meningiomas (RIMs) are limited. Methods: A single institution database of Cobalt-60 SRS cases from 08/1999...
3.
Dorsey J, Mott R, Lack C, Britt N, Ramkissoon S, Morris B, et al.
Oncol Lett
. 2022 Aug;
24(3):326.
PMID: 35949590
Gorlin syndrome or nevoid basal cell carcinoma syndrome is a rare genetic disease characterized by predisposition to congenital defects, basal cell carcinomas and medulloblastoma. The syndrome results from a heritable...
4.
Elenes E, Mehta J, Hsu F, Whitlow C, Debinski W, Rossmeisl J, et al.
J Eng Sci Med Diagn Ther
. 2022 Jul;
4(1):011003.
PMID: 35832263
Standard treatment for glioblastoma is noncurative and only partially effective. Convection-enhanced delivery (CED) was developed as an alternative approach for effective loco-regional delivery of drugs via a small catheter inserted...
5.
Sharma P, Sonawane P, Herpai D, DAgostino R, Rossmeisl J, Tatter S, et al.
Neurooncol Adv
. 2020 Nov;
2(1):vdaa107.
PMID: 33150335
Background: Treatment for glioblastoma (GBM) remains an unmet need in medicine. Novel therapies that address GBM complexity and heterogeneity in particular are warranted. To this end, we target 4 tumor-associated...
6.
Bower A, Hsu F, Weaver K, Yelton C, Merrill R, Wicks R, et al.
Neurooncol Pract
. 2020 Aug;
7(4):453-460.
PMID: 32765895
Background: Community economics and other social health determinants influence outcomes in oncologic patient populations. We sought to explore their impact on presentation, treatment, and survival in glioma patients. Methods: A...
7.
Dohm A, Hughes R, Wheless W, LeCompte M, Lanier C, Ruiz J, et al.
J Neurooncol
. 2018 Oct;
140(3):749-756.
PMID: 30367382
Purpose: The purpose of this study was to retrospectively evaluate the new treatment paradigm of staged stereotactic radiosurgery (SRS) for the treatment of large brain metastases (BM) compared to the...
8.
Zheng Z, Morykwas M, Tatter S, Gordon S, McGee M, Green H, et al.
Neurosurgery
. 2015 Oct;
78(6):868-76.
PMID: 26479704
Background: Traumatic spinal cord injury (SCI) is a major worldwide cause of mortality and disability with limited treatment options. Previous research applying controlled negative pressure to traumatic brain injury in...
9.
Zheng Z, Morykwas M, Campbell D, McGee M, Hollingsworth C, Adams F, et al.
Neurosurgery
. 2014 Mar;
75(2):152-62.
PMID: 24618796
Background: Traumatic brain injuries (TBIs) continue to be a devastating problem with limited treatment options. Previous research applying controlled vacuum to TBI in a rat model resulted in smaller injuries...
10.
Renfrow J, DeTroye A, Chan M, Tatter S, Ellis T, McMullen K, et al.
J Neurooncol
. 2012 Jan;
107(3):659-63.
PMID: 22249693
Novel therapeutic options for patients with recurrent primary central nervous system lymphoma (RPCNSL) are needed. Bendamustine, a bifunctional purine analog/alkylating agent, is approved for use in patients with progressive systemic...